The global diabetes market has witnessed significant growth, driven by the rising prevalence of diabetes and the increasing demand for advanced treatment options. As of 2023, approximately 537 million adults are living with diabetes, and this number is expected to rise to 783 million by 2045. Innovative technologies, such as continuous glucose monitoring systems and insulin delivery devices, are transforming diabetes management, enhancing patient outcomes and quality of life.
Moreover, the market is characterized by a shift towards personalized medicine, with a growing emphasis on tailored therapies based on individual patient profiles. Increasing health awareness and government initiatives promoting diabetes prevention and management are also contributing to market expansion. Additionally, the integration of digital health solutions, including telemedicine and mobile health applications, is reshaping diabetes care delivery, making it more accessible and efficient. The combination of these factors positions the diabetes market for sustained growth in the coming years.












Title : Changes in the global incidence of diabetes over a quarter century
F Buck Willis, Christian College of Medicine
Title : Beyond glucose: A dual mechanism neuroprotective strategy targeting the GPR146 SIRT1 and ADGRG1 MYC axes in alzheimer’s disease
David Petch, utR Biotech
Title : The prowess of Overripe Banana Sweetener (OBS) in enhancing nutritive values in food and ameliorating glycaemic responses in type 2 diabetes mellitus
Wan Rosli Wan Ishak, Universiti Sains Malaysia
Title : Wound care 2.0 creating a wound care culture TM
David Navazio, Gentell
Title : Beyond the prescription: Using GLP 1 science and lifestyle coaching to prevent prediabetes and support long term blood sugar control
Keith Hersey, Founder/CEO Destroying Diabetes
Title : Fetomaternal outcomes in gestational diabetes mellitus with and without polycystic ovary syndrome
Vinita Singh, AIIMS
Title : Cardiorespiratory fitness inflammatory and neurotrophic biomarkers and cognitive function in early versus longer duration type 2 diabetes mellitus
Arbind Kumar Choudhary, All India Institute of Medical Sciences
Title : Residual Maladaptation Score (RMS): A novel Risk stratification index for early identification of diabetes risk and valvular heart disease in patients with hypothyroidism beyond standard thyroid markers
Ashwin Karuppan V, Gleneagles Hospitals
Title : Biographical disruption mental health and lived experience in adolescents and young adults with type 1 diabetes
Ariela Orbea Cevallos, Universidad Internacional SEK
Title : Enhancing nutrition therapy on diabetics through increased crop productivity
Grace A Asiko, Apiculture Platform of Kenya